Tag Archives: Capitol Hill

Sequestration: How Big a Hit for FDA, Research and Pharma?

By Jill Wechsler | Published: March 12, 2013
The greatly feared federal budget sequestration mandate went into effect March 1, and, initially, the impact was fairly muted. The stock market soared, employment rose and government workers continued on their jobs. Federal agencies, including the Food and Drug Administration (FDA), launched initiatives to comply with the mandated 5% across-the-board cut in spending (in reality [...]
Posted in FDA, Legal, R&D, healthcare, leadership | Also tagged , , , , , , | Leave a comment

Paul Ryan and Pharma: The Inside Story

By Guest Blogger | Published: August 22, 2012
by Tom Norton Well, we certainly have a presidential campaign now, don’t we? Good grief. Since Rep. Paul Ryan was named the Republican VP candidate last week, all hell has broken loose!  Given the intensity of the last few days, you’d think the election was tomorrow… And at some point, you do have to ask yourself, “Really, [...]
Posted in FDA, Guest Blog, Op-Ed, healthcare | Also tagged , , , , | 3 Comments